William Febbo, OptimizeRx CEO
October 13, 2023 12:58 PM EDT
Deals
Pharma
Marketing

Op­ti­miz­eRx builds out pa­tient DTC mar­ket­ing with $95M ac­qui­si­tion

Beth Snyder Bulik

Senior Editor

Dig­i­tal phar­ma mar­ket­ing com­pa­ny Op­ti­miz­eRx on Thurs­day said it’s am­pli­fy­ing its di­rect-to-pa­tient ef­forts with the $95 mil­lion ac­qui­si­tion of Medicx Health …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times